Evidence map›Paper›PMID 28137846›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.

Justin E Lengfeld, Sarah E Lutz, Julian R Smith, Claudiu Diaconu, Cameron Scott, Sigal B Kofman, Claire Choi, Craig M Walsh, Cedric S Raine, Ilir Agalliu and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 155 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Revolutionizing Autoimmune Research: The Role of Caveolin-1.Immunity, inflammation and disease · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Single-cell Technology in Stem Cell Research.Current stem cell research & therapy · 2025
    Review
  18. Article
  19. Review
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Justin E LengfeldDepartment of Developmental and Cell Biology, University of California, Irvine, CA 92697.
Sarah E LutzDepartment of Neurology, Columbia University Medical Center, New York, NY 10032; da191@cumc.columbia.edu sl4151@cumc.columbia.edu.
Julian R SmithDepartment of Neurology, Columbia University Medical Center, New York, NY 10032.
Claudiu DiaconuDepartment of Neurology, Columbia University Medical Center, New York, NY 10032.
Cameron ScottDepartment of Developmental and Cell Biology, University of California, Irvine, CA 92697.
Sigal B KofmanDepartment of Medicine, Columbia University Medical Center, New York, NY 10032.
Claire ChoiDepartment of Neurology, Columbia University Medical Center, New York, NY 10032.
Craig M WalshDepartment of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697.
Cedric S RaineDepartment of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461.
Ilir AgalliuDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461.
Dritan AgalliuDepartment of Developmental and Cell Biology, University of California, Irvine, CA 92697; da191@cumc.columbia.edu sl4151@cumc.columbia.edu.
Columbia University Irving Medical Center · USUniversity of California, Irvine · USAlbert Einstein College of Medicine · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
Neurology Research Education and Mentorship ProgramR25NS070697 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KUO, SHENG-HAN · 2010 to 2023
$1.9M
CNS angiogenesis and blood-brain barrier regulation by the Wnt inhibitor Apcdd1.R01HL116995 · NHLBI · UNIVERSITY OF CALIFORNIA-IRVINE · PI AGALLIU, DRITAN · 2013 to 2017
$1.9M
Developing a microfluidic human neurovascular unit system to investigate genetic and age-related risk factors in Alzheimer's diseaseR01AG078352 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Dritan Agalliu, Andrew Alexander Sproul · 2025 to 2026
$837k
Th17 cell-mediated CNS damage in response to recurrent S. pyogenes intranasal infectionsR56MH109987 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AGALLIU, DRITAN, CUTFORTH, TYLER · 2016 to 2016
$400k
NCI NIH HHS P30 CA062203NHLBI NIH HHS R01 HL116995NIA NIH HHS R01 AG078352NIMH NIH HHS R56 MH109987NINDS NIH HHS R25 NS070697
6 · The paper itself

Abstract

Disruption of the blood-brain barrier (BBB) is a defining and early feature of multiple sclerosis (MS) that directly damages the central nervous system (CNS), promotes immune cell infiltration, and influences clinical outcomes. There is an urgent need for new therapies to protect and restore BBB function, either by strengthening endothelial tight junctions or suppressing endothelial vesicular transcytosis. Although wingless integrated MMTV (Wnt)/β-catenin signaling plays an essential role in BBB formation and maintenance in healthy CNS, its role in BBB repair in neurologic diseases such as MS remains unclear. Using a Wnt/β-catenin reporter mouse and several downstream targets, we demonstrate that the Wnt/β-catenin pathway is up-regulated in CNS endothelial cells in both human MS and the mouse model experimental autoimmune encephalomyelitis (EAE). Increased Wnt/β-catenin activity in CNS blood vessels during EAE progression correlates with up-regulation of neuronal Wnt3 expression, as well as breakdown of endothelial cell junctions. Genetic inhibition of the Wnt/β-catenin pathway in CNS endothelium before disease onset exacerbates the clinical presentation of EAE, CD4

Indexed as

Wnt Signaling PathwayAnimalsbeta CateninBlood-Brain BarrierCaveolin 1CD4-Positive T-LymphocytesCentral Nervous SystemEncephalomyelitis, Autoimmune, ExperimentalEndothelial CellsFemaleHumansMice, CongenicMice, Inbred C57BLMice, TransgenicMultiple SclerosisTranscytosisbeta CateninCaveolin 1blood–brain barrierEAEendothelial cellMSWnt/β-catenin signaling

Identifiers

PMID28137846
PMCPMC5320985
OpenAlexW2580746852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.